Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B

NCT01369199 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

28

Enrollment

NIH

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Entecavir and peginterferon

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]